Amedisys Inc. (AMED) Short Interest Down 60.2% in September

Amedisys Inc. (NASDAQ:AMED) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totalling 1,114,930 shares, a decrease of 60.2% from the September 15th total of 2,803,524 shares. Based on an average daily volume of 227,857 shares, the short-interest ratio is presently 4.9 days. Currently, 3.4% of the shares of the stock are short sold.

Shares of Amedisys (NASDAQ:AMED) opened at 46.12 on Wednesday. Amedisys has a 52 week low of $31.16 and a 52 week high of $55.16. The stock has a 50 day moving average price of $47.74 and a 200 day moving average price of $49.83. The firm has a market cap of $1.55 billion, a PE ratio of 40.35 and a beta of 0.96.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.42. The company earned $360 million during the quarter, compared to analyst estimates of $353.07 million. Amedisys had a return on equity of 12.17% and a net margin of 2.78%. The firm’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter last year, the company earned $0.43 earnings per share. Equities analysts expect that Amedisys will post $1.69 earnings per share for the current year.

A number of equities analysts have issued reports on the company. Zacks Investment Research raised Amedisys from a “hold” rating to a “buy” rating and set a $57.00 target price for the company in a report on Tuesday, July 5th. Wells Fargo & Co. reaffirmed a “buy” rating on shares of Amedisys in a report on Sunday, September 11th. Mizuho cut Amedisys from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $57.00 to $55.00 in a report on Wednesday, August 3rd. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Amedisys in a report on Tuesday, September 6th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $51.75.

Large investors have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its stake in Amedisys by 81.1% in the first quarter. Renaissance Technologies LLC now owns 630,901 shares of the company’s stock valued at $30,498,000 after buying an additional 282,600 shares in the last quarter. Prudential Financial Inc. raised its stake in shares of Amedisys by 2.8% in the first quarter. Prudential Financial Inc. now owns 75,959 shares of the company’s stock valued at $3,672,000 after buying an additional 2,100 shares during the period. M&T Bank Corp purchased a new stake in shares of Amedisys during the first quarter valued at about $367,000. BlackRock Inc. raised its stake in shares of Amedisys by 7.0% in the first quarter. BlackRock Inc. now owns 123,381 shares of the company’s stock valued at $5,964,000 after buying an additional 8,077 shares during the period. Finally, A.R.T. Advisors LLC raised its stake in shares of Amedisys by 77.5% in the first quarter. A.R.T. Advisors LLC now owns 50,626 shares of the company’s stock valued at $2,447,000 after buying an additional 22,100 shares during the period. 91.43% of the stock is owned by institutional investors.

Amedisys Company Profile

Amedisys, Inc (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks.

5 Day Chart for NASDAQ:AMED

Receive News & Ratings for Amedisys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Michael Jordan Gains Ground on Getting His Name Back
Michael Jordan Gains Ground on Getting His Name Back
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday


 
© 2006-2016 Ticker Report. Google+.